Ocular Therapeutix
OCUL
OCUL
140 hedge funds and large institutions have $288M invested in Ocular Therapeutix in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 51 increasing their positions, 42 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
3.95% less ownership
Funds ownership: 58.16% → 54.21% (-3.9%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
35% less capital invested
Capital invested by funds: $445M → $288M (-$157M)
Holders
140
Holding in Top 10
4
Calls
$2.1M
Puts
$2.17M
Top Buyers
| 1 | +$10.4M | |
| 2 | +$4.33M | |
| 3 | +$2.75M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.72M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$1.69M |
Top Sellers
| 1 | -$11.4M | |
| 2 | -$7.5M | |
| 3 | -$7.5M | |
| 4 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$6.78M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$3.55M |